Ron Martell
SVP, COMMERCIAL OPERATIONS, IMCLONE SYSTEMS INC.
Companies
- Jasper Therapeutics, Inc.Board member Mar 21, 2022 to now1
- Jasper Therapeutics, Inc.Chief executive officer Mar 21, 2022 to Feb 10, 20261
- Jasper Therapeutics, Inc.President Mar 21, 2022 to Feb 10, 20261
- Plus TherapeuticsBoard member Jan 3, 2017 to Jan 27, 20172
- HUMANIGEN, INCChair May 28, 2015 to Oct 28, 20153
- HUMANIGEN, INCBoard member Apr 23, 2015 to Apr 27, 20154
- Eloxx Pharmaceuticals, Inc.Board member Jun 26, 2014 to Nov 20, 20145
- Eloxx Pharmaceuticals, Inc.Chief executive officer Jun 26, 2014 to Nov 20, 20145
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Jasper Therapeutics, Inc. JSPR74,118 shares6$35.3K at $0.48Sep 22, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 22, 2025Bought 41,000 shares at $2.43 of Jasper Therapeutics, Inc.6
- Oct 12, 2023Shares withheld for tax 87,531 shares at $0.85 of Jasper Therapeutics, Inc.7
- Apr 12, 2023Shares withheld for tax 87,531 shares at $1.46 of Jasper Therapeutics, Inc.8
- Oct 12, 2022Granted 506,250 shares of Jasper Therapeutics, Inc.9
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARPlus Therapeutics, Board member
- 3SEC EDGARHUMANIGEN, INC, Chair
- 4SEC EDGARHUMANIGEN, INC, Board member
- 5
- 6
- 7SEC EDGARForm 4 filed Oct 13, 2023
- 8SEC EDGARForm 4 filed Apr 14, 2023
- 9SEC EDGARForm 4 filed Oct 13, 2022